Sanofi starts Dutch auction for 30% of Genzyme CVRs
14:14 EDT 4 Sep 2012 | BioCentury
Sanofi (Euronext:SAN; NYSE:SNY) launched a modified Dutch auction tender offer to purchase up to 86.8 million, or about 30%, of the outstanding Genzyme Corp. contingent value rights at a price range of $1.50-$1.75. The range is a 7-25% premium to the..
Original Article: Sanofi starts Dutch auction for 30% of Genzyme CVRs
More From BioPortfolio on "Sanofi starts Dutch auction for 30% of Genzyme CVRs"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
